NEW YORK, April 17 – Luminex has licensed its LabMap technology to ARUP Laboratories, a national specialty diagnostic reference laboratory, the company said Tuesday.

Under the agreement, ARUP will use Luminex’s technology to develop clinical laboratory assays for antibodies to common disease agents, such as Streptococcus pneumoniae  and mitogens. Luminex will receive royalties on the sale of these diagnostic tests. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

British Nobel laureates and Fields Medal winners warn that a 'hard' Brexit could harm science across the UK, the Guardian reports.

Vox reports on inequities in genetic research and efforts to address them.

The New York Times reports that Arizona State University's Lawrence Krauss is retiring following allegations of sexual misconduct.

In PNAS this week: de novo NUS1 mutations linked to Parkinson's disease risk, candidate hepatocellular carcinoma drivers, and more.